The vanishingly rare, progressive, and debilitating disease is caused by a deficiency in the enzyme alpha-mannosidase, leading to a build-up of complex sugars that damage the central nervous ...
Affecting approximately one in every 500,000 to one in every one million babies born worldwide, AM is a rare inherited metabolic disorder caused by a deficiency of the enzyme alpha-mannosidase.
The report abides by quality and quantity. It covers the major strategic market developments, including R&D, M&A, agreements, new products launch, collaborations, partnerships, joint ventures, and ...